SAMUEL MADRID: Open Payments
NPI 1407418932 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 21 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 9 | $326 |
| GENZYME CORPORATION | 6 | $252 |
| GlaxoSmithKline, LLC. | 4 | $196 |
| Integra LifeSciences Corporation | 1 | $166 |
| Phadia US Inc. | 1 | $58 |
Products named: DAWNZERA, DUPIXENT, NUCALA, ACCLARENT AERA, ImmunoCAP.
Industry payments across AZ — which companies pay providers there.
